Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: TechNavio | PRODUCT CODE: 1248804

Cover Image

PUBLISHER: TechNavio | PRODUCT CODE: 1248804

Global Antimicrobial Therapeutics Market 2023-2027

PUBLISHED:
PAGES: 167 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 2500
PDF (Enterprise License)
USD 4000

Add to Cart

Technavio has been monitoring the antimicrobial therapeutics market and is forecast to grow by USD 51.4 bn during 2022-2027, accelerating at a CAGR of 5.63% during the forecast period. Our report on the antimicrobial therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by recent drug approvals and robust pipeline, initiatives from government agencies in pharmaceutical industry, and rising awareness about microbial diseases.

Technavio's antimicrobial therapeutics market is segmented as below:

By Application

  • Antiviral
  • Antibacterial
  • Antifungal
  • Antiparasitic

By End-user

  • Pharmacies
  • Hospitals and clinics
  • Research and academic institutes

By Geographical

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

This study identifies the increase in research and development of therapeutic vaccines as one of the prime reasons driving the antimicrobial therapeutics market growth during the next few years. Also, increased disease diagnostic modalities and increasing research on combination therapies will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the antimicrobial therapeutics market covers the following areas:

  • Antimicrobial therapeutics market sizing
  • Antimicrobial therapeutics market forecast
  • Antimicrobial therapeutics market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading antimicrobial therapeutics market vendors that include AbbVie Inc., Astellas Pharma Inc., Bavarian Nordic AS, Biocidium Biopharmaceuticals Inc., Bristol Myers Squibb Co., Cadila Pharmaceuticals Ltd., CSL Ltd., Emergent BioSolutions Inc., F. Hoffmann La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline Plc, Inovio Pharmaceuticals Inc., Johnson and Johnson Services Inc., Merck and Co. Inc., Mitsubishi Tanabe Pharma Corp., Novartis AG, Novavax Inc., Pfizer Inc., Sanofi SA, and Wockhardt Ltd. Also, the antimicrobial therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Product Code: IRTNTR43391

Table of Contents

1 Executive Summary

  • 1.1 Market overview
  • Exhibit 01: Executive Summary - Chart on Market Overview
  • Exhibit 02: Executive Summary - Data Table on Market Overview
  • Exhibit 03: Executive Summary - Chart on Global Market Characteristics
  • Exhibit 04: Executive Summary - Chart on Market By Geographical
  • Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
  • Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
  • Exhibit 07: Executive Summary - Chart on Incremental Growth
  • Exhibit 08: Executive Summary - Data Table on Incremental Growth
  • Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
  • Exhibit 10: Parent market
  • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
  • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
  • Exhibit 13: Market segments
  • 3.3 Market size 2022
  • 3.4 Market outlook: Forecast for 2022-2027
  • Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
  • Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

  • 4.1 Global antimicrobial therapeutics market 2017 - 2021
  • Exhibit 18: Historic Market Size - Data Table on Global antimicrobial therapeutics market 2017 - 2021 ($ billion)
  • 4.2 Application Segment Analysis 2017 - 2021
  • Exhibit 19: Historic Market Size - Application Segment 2017 - 2021 ($ billion)
  • 4.3 End-user Segment Analysis 2017 - 2021
  • Exhibit 20: Historic Market Size - End-user Segment 2017 - 2021 ($ billion)
  • 4.4 Geography Segment Analysis 2017 - 2021
  • Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
  • 4.5 Country Segment Analysis 2017 - 2021
  • Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)

5 Five Forces Analysis

  • 5.1 Five forces summary
  • Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
  • 5.2 Bargaining power of buyers
  • Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
  • 5.3 Bargaining power of suppliers
  • Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
  • 5.4 Threat of new entrants
  • Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
  • 5.5 Threat of substitutes
  • Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
  • 5.6 Threat of rivalry
  • Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
  • 5.7 Market condition
  • Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Application

  • 6.1 Market segments
  • Exhibit 30: Chart on Application - Market share 2022-2027 (%)
  • Exhibit 31: Data Table on Application - Market share 2022-2027 (%)
  • 6.2 Comparison by Application
  • Exhibit 32: Chart on Comparison by Application
  • Exhibit 33: Data Table on Comparison by Application
  • 6.3 Antiviral - Market size and forecast 2022-2027
  • Exhibit 34: Chart on Antiviral - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 35: Data Table on Antiviral - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 36: Chart on Antiviral - Year-over-year growth 2022-2027 (%)
  • Exhibit 37: Data Table on Antiviral - Year-over-year growth 2022-2027 (%)
  • 6.4 Antibacterial - Market size and forecast 2022-2027
  • Exhibit 38: Chart on Antibacterial - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 39: Data Table on Antibacterial - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 40: Chart on Antibacterial - Year-over-year growth 2022-2027 (%)
  • Exhibit 41: Data Table on Antibacterial - Year-over-year growth 2022-2027 (%)
  • 6.5 Antifungal - Market size and forecast 2022-2027
  • Exhibit 42: Chart on Antifungal - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 43: Data Table on Antifungal - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 44: Chart on Antifungal - Year-over-year growth 2022-2027 (%)
  • Exhibit 45: Data Table on Antifungal - Year-over-year growth 2022-2027 (%)
  • 6.6 Antiparasitic - Market size and forecast 2022-2027
  • Exhibit 46: Chart on Antiparasitic - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 47: Data Table on Antiparasitic - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 48: Chart on Antiparasitic - Year-over-year growth 2022-2027 (%)
  • Exhibit 49: Data Table on Antiparasitic - Year-over-year growth 2022-2027 (%)
  • 6.7 Market opportunity by Application
  • Exhibit 50: Market opportunity by Application ($ billion)
  • Exhibit 51: Data Table on Market opportunity by Application ($ billion)

7 Market Segmentation by End-user

  • 7.1 Market segments
  • Exhibit 52: Chart on End-user - Market share 2022-2027 (%)
  • Exhibit 53: Data Table on End-user - Market share 2022-2027 (%)
  • 7.2 Comparison by End-user
  • Exhibit 54: Chart on Comparison by End-user
  • Exhibit 55: Data Table on Comparison by End-user
  • 7.3 Pharmacies - Market size and forecast 2022-2027
  • Exhibit 56: Chart on Pharmacies - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 57: Data Table on Pharmacies - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 58: Chart on Pharmacies - Year-over-year growth 2022-2027 (%)
  • Exhibit 59: Data Table on Pharmacies - Year-over-year growth 2022-2027 (%)
  • 7.4 Hospitals and clinics - Market size and forecast 2022-2027
  • Exhibit 60: Chart on Hospitals and clinics - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 61: Data Table on Hospitals and clinics - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 62: Chart on Hospitals and clinics - Year-over-year growth 2022-2027 (%)
  • Exhibit 63: Data Table on Hospitals and clinics - Year-over-year growth 2022-2027 (%)
  • 7.5 Research and academic institutes - Market size and forecast 2022-2027
  • Exhibit 64: Chart on Research and academic institutes - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 65: Data Table on Research and academic institutes - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 66: Chart on Research and academic institutes - Year-over-year growth 2022-2027 (%)
  • Exhibit 67: Data Table on Research and academic institutes - Year-over-year growth 2022-2027 (%)
  • 7.6 Market opportunity by End-user
  • Exhibit 68: Market opportunity by End-user ($ billion)
  • Exhibit 69: Data Table on Market opportunity by End-user ($ billion)

8 Customer Landscape

  • 8.1 Customer landscape overview
  • Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

  • 9.1 Geographic segmentation
  • Exhibit 71: Chart on Market share By Geographical 2022-2027 (%)
  • Exhibit 72: Data Table on Market share By Geographical 2022-2027 (%)
  • 9.2 Geographic comparison
  • Exhibit 73: Chart on Geographic comparison
  • Exhibit 74: Data Table on Geographic comparison
  • 9.3 North America - Market size and forecast 2022-2027
  • Exhibit 75: Chart on North America - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 76: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 77: Chart on North America - Year-over-year growth 2022-2027 (%)
  • Exhibit 78: Data Table on North America - Year-over-year growth 2022-2027 (%)
  • 9.4 Europe - Market size and forecast 2022-2027
  • Exhibit 79: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 80: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 81: Chart on Europe - Year-over-year growth 2022-2027 (%)
  • Exhibit 82: Data Table on Europe - Year-over-year growth 2022-2027 (%)
  • 9.5 Asia - Market size and forecast 2022-2027
  • Exhibit 83: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 84: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 85: Chart on Asia - Year-over-year growth 2022-2027 (%)
  • Exhibit 86: Data Table on Asia - Year-over-year growth 2022-2027 (%)
  • 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
  • Exhibit 87: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 88: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 89: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • Exhibit 90: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • 9.7 US - Market size and forecast 2022-2027
  • Exhibit 91: Chart on US - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 92: Data Table on US - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 93: Chart on US - Year-over-year growth 2022-2027 (%)
  • Exhibit 94: Data Table on US - Year-over-year growth 2022-2027 (%)
  • 9.8 China - Market size and forecast 2022-2027
  • Exhibit 95: Chart on China - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 96: Data Table on China - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 97: Chart on China - Year-over-year growth 2022-2027 (%)
  • Exhibit 98: Data Table on China - Year-over-year growth 2022-2027 (%)
  • 9.9 Germany - Market size and forecast 2022-2027
  • Exhibit 99: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 100: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 101: Chart on Germany - Year-over-year growth 2022-2027 (%)
  • Exhibit 102: Data Table on Germany - Year-over-year growth 2022-2027 (%)
  • 9.10 France - Market size and forecast 2022-2027
  • Exhibit 103: Chart on France - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 104: Data Table on France - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 105: Chart on France - Year-over-year growth 2022-2027 (%)
  • Exhibit 106: Data Table on France - Year-over-year growth 2022-2027 (%)
  • 9.11 Japan - Market size and forecast 2022-2027
  • Exhibit 107: Chart on Japan - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 108: Data Table on Japan - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 109: Chart on Japan - Year-over-year growth 2022-2027 (%)
  • Exhibit 110: Data Table on Japan - Year-over-year growth 2022-2027 (%)
  • 9.12 Market opportunity By Geographical
  • Exhibit 111: Market opportunity By Geographical ($ billion)
  • Exhibit 112: Data Tables on Market opportunity By Geographical ($ billion)

10 Drivers, Challenges, and Trends

  • 10.1 Market drivers
  • 10.2 Market challenges
  • 10.3 Impact of drivers and challenges
  • Exhibit 113: Impact of drivers and challenges in 2022 and 2027
  • 10.4 Market trends

11 Vendor Landscape

  • 11.1 Overview
  • 11.2 Vendor landscape
  • Exhibit 114: Overview on Criticality of inputs and Factors of differentiation
  • 11.3 Landscape disruption
  • Exhibit 115: Overview on factors of disruption
  • 11.4 Industry risks
  • Exhibit 116: Impact of key risks on business

12 Vendor Analysis

  • 12.1 Vendors covered
  • Exhibit 117: Vendors covered
  • 12.2 Market positioning of vendors
  • Exhibit 118: Matrix on vendor position and classification
  • 12.3 AbbVie Inc.
  • Exhibit 119: AbbVie Inc. - Overview
  • Exhibit 120: AbbVie Inc. - Product / Service
  • Exhibit 121: AbbVie Inc. - Key news
  • Exhibit 122: AbbVie Inc. - Key offerings
  • 12.4 Astellas Pharma Inc.
  • Exhibit 123: Astellas Pharma Inc. - Overview
  • Exhibit 124: Astellas Pharma Inc. - Product / Service
  • Exhibit 125: Astellas Pharma Inc. - Key news
  • Exhibit 126: Astellas Pharma Inc. - Key offerings
  • 12.5 Bavarian Nordic AS
  • Exhibit 127: Bavarian Nordic AS - Overview
  • Exhibit 128: Bavarian Nordic AS - Product / Service
  • Exhibit 129: Bavarian Nordic AS - Key offerings
  • 12.6 Biocidium Biopharmaceuticals Inc.
  • Exhibit 130: Biocidium Biopharmaceuticals Inc. - Overview
  • Exhibit 131: Biocidium Biopharmaceuticals Inc. - Product / Service
  • Exhibit 132: Biocidium Biopharmaceuticals Inc. - Key offerings
  • 12.7 Bristol Myers Squibb Co.
  • Exhibit 133: Bristol Myers Squibb Co. - Overview
  • Exhibit 134: Bristol Myers Squibb Co. - Product / Service
  • Exhibit 135: Bristol Myers Squibb Co. - Key news
  • Exhibit 136: Bristol Myers Squibb Co. - Key offerings
  • 12.8 Cadila Pharmaceuticals Ltd.
  • Exhibit 137: Cadila Pharmaceuticals Ltd. - Overview
  • Exhibit 138: Cadila Pharmaceuticals Ltd. - Product / Service
  • Exhibit 139: Cadila Pharmaceuticals Ltd. - Key offerings
  • 12.9 CSL Ltd.
  • Exhibit 140: CSL Ltd. - Overview
  • Exhibit 141: CSL Ltd. - Business segments
  • Exhibit 142: CSL Ltd. - Key news
  • Exhibit 143: CSL Ltd. - Key offerings
  • Exhibit 144: CSL Ltd. - Segment focus
  • 12.10 F. Hoffmann La Roche Ltd.
  • Exhibit 145: F. Hoffmann La Roche Ltd. - Overview
  • Exhibit 146: F. Hoffmann La Roche Ltd. - Business segments
  • Exhibit 147: F. Hoffmann La Roche Ltd. - Key news
  • Exhibit 148: F. Hoffmann La Roche Ltd. - Key offerings
  • Exhibit 149: F. Hoffmann La Roche Ltd. - Segment focus
  • 12.11 Gilead Sciences Inc.
  • Exhibit 150: Gilead Sciences Inc. - Overview
  • Exhibit 151: Gilead Sciences Inc. - Product / Service
  • Exhibit 152: Gilead Sciences Inc. - Key news
  • Exhibit 153: Gilead Sciences Inc. - Key offerings
  • 12.12 GlaxoSmithKline Plc
  • Exhibit 154: GlaxoSmithKline Plc - Overview
  • Exhibit 155: GlaxoSmithKline Plc - Business segments
  • Exhibit 156: GlaxoSmithKline Plc - Key news
  • Exhibit 157: GlaxoSmithKline Plc - Key offerings
  • Exhibit 158: GlaxoSmithKline Plc - Segment focus
  • 12.13 Johnson and Johnson Services Inc.
  • Exhibit 159: Johnson and Johnson Services Inc. - Overview
  • Exhibit 160: Johnson and Johnson Services Inc. - Business segments
  • Exhibit 161: Johnson and Johnson Services Inc. - Key news
  • Exhibit 162: Johnson and Johnson Services Inc. - Key offerings
  • Exhibit 163: Johnson and Johnson Services Inc. - Segment focus
  • 12.14 Merck and Co. Inc.
  • Exhibit 164: Merck and Co. Inc. - Overview
  • Exhibit 165: Merck and Co. Inc. - Business segments
  • Exhibit 166: Merck and Co. Inc. - Key news
  • Exhibit 167: Merck and Co. Inc. - Key offerings
  • Exhibit 168: Merck and Co. Inc. - Segment focus
  • 12.15 Novartis AG
  • Exhibit 169: Novartis AG - Overview
  • Exhibit 170: Novartis AG - Business segments
  • Exhibit 171: Novartis AG - Key offerings
  • Exhibit 172: Novartis AG - Segment focus
  • 12.16 Pfizer Inc.
  • Exhibit 173: Pfizer Inc. - Overview
  • Exhibit 174: Pfizer Inc. - Product / Service
  • Exhibit 175: Pfizer Inc. - Key news
  • Exhibit 176: Pfizer Inc. - Key offerings
  • 12.17 Sanofi SA
  • Exhibit 177: Sanofi SA - Overview
  • Exhibit 178: Sanofi SA - Business segments
  • Exhibit 179: Sanofi SA - Key news
  • Exhibit 180: Sanofi SA - Key offerings
  • Exhibit 181: Sanofi SA - Segment focus

13 Appendix

  • 13.1 Scope of the report
  • 13.2 Inclusions and exclusions checklist
  • Exhibit 182: Inclusions checklist
  • Exhibit 183: Exclusions checklist
  • 13.3 Currency conversion rates for US$
  • Exhibit 184: Currency conversion rates for US$
  • 13.4 Research methodology
  • Exhibit 185: Research methodology
  • Exhibit 186: Validation techniques employed for market sizing
  • Exhibit 187: Information sources
  • 13.5 List of abbreviations
  • Exhibit 188: List of abbreviations
Product Code: IRTNTR43391

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical
  • Exhibits5: Executive Summary - Chart on Market Segmentation by Application
  • Exhibits6: Executive Summary - Chart on Market Segmentation by End-user
  • Exhibits7: Executive Summary - Chart on Incremental Growth
  • Exhibits8: Executive Summary - Data Table on Incremental Growth
  • Exhibits9: Executive Summary - Chart on Vendor Market Positioning
  • Exhibits10: Parent market
  • Exhibits11: Market Characteristics
  • Exhibits12: Offerings of vendors included in the market definition
  • Exhibits13: Market segments
  • Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
  • Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
  • Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
  • Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
  • Exhibits18: Historic Market Size - Data Table on Global antimicrobial therapeutics market 2017 - 2021 ($ billion)
  • Exhibits19: Historic Market Size - Application Segment 2017 - 2021 ($ billion)
  • Exhibits20: Historic Market Size - End-user Segment 2017 - 2021 ($ billion)
  • Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
  • Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)
  • Exhibits23: Five forces analysis - Comparison between 2022 and 2027
  • Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
  • Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
  • Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
  • Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
  • Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
  • Exhibits29: Chart on Market condition - Five forces 2022 and 2027
  • Exhibits30: Chart on Application - Market share 2022-2027 (%)
  • Exhibits31: Data Table on Application - Market share 2022-2027 (%)
  • Exhibits32: Chart on Comparison by Application
  • Exhibits33: Data Table on Comparison by Application
  • Exhibits34: Chart on Antiviral - Market size and forecast 2022-2027 ($ billion)
  • Exhibits35: Data Table on Antiviral - Market size and forecast 2022-2027 ($ billion)
  • Exhibits36: Chart on Antiviral - Year-over-year growth 2022-2027 (%)
  • Exhibits37: Data Table on Antiviral - Year-over-year growth 2022-2027 (%)
  • Exhibits38: Chart on Antibacterial - Market size and forecast 2022-2027 ($ billion)
  • Exhibits39: Data Table on Antibacterial - Market size and forecast 2022-2027 ($ billion)
  • Exhibits40: Chart on Antibacterial - Year-over-year growth 2022-2027 (%)
  • Exhibits41: Data Table on Antibacterial - Year-over-year growth 2022-2027 (%)
  • Exhibits42: Chart on Antifungal - Market size and forecast 2022-2027 ($ billion)
  • Exhibits43: Data Table on Antifungal - Market size and forecast 2022-2027 ($ billion)
  • Exhibits44: Chart on Antifungal - Year-over-year growth 2022-2027 (%)
  • Exhibits45: Data Table on Antifungal - Year-over-year growth 2022-2027 (%)
  • Exhibits46: Chart on Antiparasitic - Market size and forecast 2022-2027 ($ billion)
  • Exhibits47: Data Table on Antiparasitic - Market size and forecast 2022-2027 ($ billion)
  • Exhibits48: Chart on Antiparasitic - Year-over-year growth 2022-2027 (%)
  • Exhibits49: Data Table on Antiparasitic - Year-over-year growth 2022-2027 (%)
  • Exhibits50: Market opportunity by Application ($ billion)
  • Exhibits51: Data Table on Market opportunity by Application ($ billion)
  • Exhibits52: Chart on End-user - Market share 2022-2027 (%)
  • Exhibits53: Data Table on End-user - Market share 2022-2027 (%)
  • Exhibits54: Chart on Comparison by End-user
  • Exhibits55: Data Table on Comparison by End-user
  • Exhibits56: Chart on Pharmacies - Market size and forecast 2022-2027 ($ billion)
  • Exhibits57: Data Table on Pharmacies - Market size and forecast 2022-2027 ($ billion)
  • Exhibits58: Chart on Pharmacies - Year-over-year growth 2022-2027 (%)
  • Exhibits59: Data Table on Pharmacies - Year-over-year growth 2022-2027 (%)
  • Exhibits60: Chart on Hospitals and clinics - Market size and forecast 2022-2027 ($ billion)
  • Exhibits61: Data Table on Hospitals and clinics - Market size and forecast 2022-2027 ($ billion)
  • Exhibits62: Chart on Hospitals and clinics - Year-over-year growth 2022-2027 (%)
  • Exhibits63: Data Table on Hospitals and clinics - Year-over-year growth 2022-2027 (%)
  • Exhibits64: Chart on Research and academic institutes - Market size and forecast 2022-2027 ($ billion)
  • Exhibits65: Data Table on Research and academic institutes - Market size and forecast 2022-2027 ($ billion)
  • Exhibits66: Chart on Research and academic institutes - Year-over-year growth 2022-2027 (%)
  • Exhibits67: Data Table on Research and academic institutes - Year-over-year growth 2022-2027 (%)
  • Exhibits68: Market opportunity by End-user ($ billion)
  • Exhibits69: Data Table on Market opportunity by End-user ($ billion)
  • Exhibits70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits71: Chart on Market share By Geographical 2022-2027 (%)
  • Exhibits72: Data Table on Market share By Geographical 2022-2027 (%)
  • Exhibits73: Chart on Geographic comparison
  • Exhibits74: Data Table on Geographic comparison
  • Exhibits75: Chart on North America - Market size and forecast 2022-2027 ($ billion)
  • Exhibits76: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
  • Exhibits77: Chart on North America - Year-over-year growth 2022-2027 (%)
  • Exhibits78: Data Table on North America - Year-over-year growth 2022-2027 (%)
  • Exhibits79: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
  • Exhibits80: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
  • Exhibits81: Chart on Europe - Year-over-year growth 2022-2027 (%)
  • Exhibits82: Data Table on Europe - Year-over-year growth 2022-2027 (%)
  • Exhibits83: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
  • Exhibits84: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
  • Exhibits85: Chart on Asia - Year-over-year growth 2022-2027 (%)
  • Exhibits86: Data Table on Asia - Year-over-year growth 2022-2027 (%)
  • Exhibits87: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
  • Exhibits88: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
  • Exhibits89: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • Exhibits90: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • Exhibits91: Chart on US - Market size and forecast 2022-2027 ($ billion)
  • Exhibits92: Data Table on US - Market size and forecast 2022-2027 ($ billion)
  • Exhibits93: Chart on US - Year-over-year growth 2022-2027 (%)
  • Exhibits94: Data Table on US - Year-over-year growth 2022-2027 (%)
  • Exhibits95: Chart on China - Market size and forecast 2022-2027 ($ billion)
  • Exhibits96: Data Table on China - Market size and forecast 2022-2027 ($ billion)
  • Exhibits97: Chart on China - Year-over-year growth 2022-2027 (%)
  • Exhibits98: Data Table on China - Year-over-year growth 2022-2027 (%)
  • Exhibits99: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
  • Exhibits100: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
  • Exhibits101: Chart on Germany - Year-over-year growth 2022-2027 (%)
  • Exhibits102: Data Table on Germany - Year-over-year growth 2022-2027 (%)
  • Exhibits103: Chart on France - Market size and forecast 2022-2027 ($ billion)
  • Exhibits104: Data Table on France - Market size and forecast 2022-2027 ($ billion)
  • Exhibits105: Chart on France - Year-over-year growth 2022-2027 (%)
  • Exhibits106: Data Table on France - Year-over-year growth 2022-2027 (%)
  • Exhibits107: Chart on Japan - Market size and forecast 2022-2027 ($ billion)
  • Exhibits108: Data Table on Japan - Market size and forecast 2022-2027 ($ billion)
  • Exhibits109: Chart on Japan - Year-over-year growth 2022-2027 (%)
  • Exhibits110: Data Table on Japan - Year-over-year growth 2022-2027 (%)
  • Exhibits111: Market opportunity By Geographical ($ billion)
  • Exhibits112: Data Tables on Market opportunity By Geographical ($ billion)
  • Exhibits113: Impact of drivers and challenges in 2022 and 2027
  • Exhibits114: Overview on Criticality of inputs and Factors of differentiation
  • Exhibits115: Overview on factors of disruption
  • Exhibits116: Impact of key risks on business
  • Exhibits117: Vendors covered
  • Exhibits118: Matrix on vendor position and classification
  • Exhibits119: AbbVie Inc. - Overview
  • Exhibits120: AbbVie Inc. - Product / Service
  • Exhibits121: AbbVie Inc. - Key news
  • Exhibits122: AbbVie Inc. - Key offerings
  • Exhibits123: Astellas Pharma Inc. - Overview
  • Exhibits124: Astellas Pharma Inc. - Product / Service
  • Exhibits125: Astellas Pharma Inc. - Key news
  • Exhibits126: Astellas Pharma Inc. - Key offerings
  • Exhibits127: Bavarian Nordic AS - Overview
  • Exhibits128: Bavarian Nordic AS - Product / Service
  • Exhibits129: Bavarian Nordic AS - Key offerings
  • Exhibits130: Biocidium Biopharmaceuticals Inc. - Overview
  • Exhibits131: Biocidium Biopharmaceuticals Inc. - Product / Service
  • Exhibits132: Biocidium Biopharmaceuticals Inc. - Key offerings
  • Exhibits133: Bristol Myers Squibb Co. - Overview
  • Exhibits134: Bristol Myers Squibb Co. - Product / Service
  • Exhibits135: Bristol Myers Squibb Co. - Key news
  • Exhibits136: Bristol Myers Squibb Co. - Key offerings
  • Exhibits137: Cadila Pharmaceuticals Ltd. - Overview
  • Exhibits138: Cadila Pharmaceuticals Ltd. - Product / Service
  • Exhibits139: Cadila Pharmaceuticals Ltd. - Key offerings
  • Exhibits140: CSL Ltd. - Overview
  • Exhibits141: CSL Ltd. - Business segments
  • Exhibits142: CSL Ltd. - Key news
  • Exhibits143: CSL Ltd. - Key offerings
  • Exhibits144: CSL Ltd. - Segment focus
  • Exhibits145: F. Hoffmann La Roche Ltd. - Overview
  • Exhibits146: F. Hoffmann La Roche Ltd. - Business segments
  • Exhibits147: F. Hoffmann La Roche Ltd. - Key news
  • Exhibits148: F. Hoffmann La Roche Ltd. - Key offerings
  • Exhibits149: F. Hoffmann La Roche Ltd. - Segment focus
  • Exhibits150: Gilead Sciences Inc. - Overview
  • Exhibits151: Gilead Sciences Inc. - Product / Service
  • Exhibits152: Gilead Sciences Inc. - Key news
  • Exhibits153: Gilead Sciences Inc. - Key offerings
  • Exhibits154: GlaxoSmithKline Plc - Overview
  • Exhibits155: GlaxoSmithKline Plc - Business segments
  • Exhibits156: GlaxoSmithKline Plc - Key news
  • Exhibits157: GlaxoSmithKline Plc - Key offerings
  • Exhibits158: GlaxoSmithKline Plc - Segment focus
  • Exhibits159: Johnson and Johnson Services Inc. - Overview
  • Exhibits160: Johnson and Johnson Services Inc. - Business segments
  • Exhibits161: Johnson and Johnson Services Inc. - Key news
  • Exhibits162: Johnson and Johnson Services Inc. - Key offerings
  • Exhibits163: Johnson and Johnson Services Inc. - Segment focus
  • Exhibits164: Merck and Co. Inc. - Overview
  • Exhibits165: Merck and Co. Inc. - Business segments
  • Exhibits166: Merck and Co. Inc. - Key news
  • Exhibits167: Merck and Co. Inc. - Key offerings
  • Exhibits168: Merck and Co. Inc. - Segment focus
  • Exhibits169: Novartis AG - Overview
  • Exhibits170: Novartis AG - Business segments
  • Exhibits171: Novartis AG - Key offerings
  • Exhibits172: Novartis AG - Segment focus
  • Exhibits173: Pfizer Inc. - Overview
  • Exhibits174: Pfizer Inc. - Product / Service
  • Exhibits175: Pfizer Inc. - Key news
  • Exhibits176: Pfizer Inc. - Key offerings
  • Exhibits177: Sanofi SA - Overview
  • Exhibits178: Sanofi SA - Business segments
  • Exhibits179: Sanofi SA - Key news
  • Exhibits180: Sanofi SA - Key offerings
  • Exhibits181: Sanofi SA - Segment focus
  • Exhibits182: Inclusions checklist
  • Exhibits183: Exclusions checklist
  • Exhibits184: Currency conversion rates for US$
  • Exhibits185: Research methodology
  • Exhibits186: Validation techniques employed for market sizing
  • Exhibits187: Information sources
  • Exhibits188: List of abbreviations
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!